JAMA Clinical Reviews JAMA Network

Severe pulmonary infections are a leading cause of death in adults worldwide. Romain Pirracchio, MD, MPH, PhD, of the University of California-San Francisco, joins JAMA Deputy Editor Kristin L. Walter, MD, MS, to discuss Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections.

Related Content:
Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections

Approximately 9% of US adults experience major depression each year, with lifetime prevalence nearly 17% for men and 30% for women. Effective first-line depression treatments include forms of psychotherapy and medication. Close monitoring significantly improves likelihood of treatment success. Gregory E. Simon, MD, MPH, discusses depression treatment with JAMA Senior Editor Karen E. Lasser, MD, MPH.

Related Content:
Management of Depression in Adults

Homelessness is detrimental to health and clinicians can play an important role in mitigating the deleterious effects of homelessness. Margot Kushel, MD, University of California, San Francisco, discusses this and more with JAMA Senior Editor Karen E. Lasser, MD, MPH.

Related Content:
Health Care for People Experiencing Homelessness

Interview with Li Li, MD, PhD, MPH, USPSTF member and coauthor of Interventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.

Related Content:
Interventions to Prevent Falls in Community-Dwelling Older Adults Interventions to Prevent Falls in Older Adults Preventing Falls in Older Persons Prevention of Falls in Older Adults

Respiratory syncytial virus (RSV) is a common infection that may cause severe illness in infants, young children, and older adults. Kathleen A. Linder, MD, of the VA Ann Arbor Healthcare System, discusses therapies to prevent severe RSV illness with JAMA Deputy Editor Kristin Walter, MD, MS.

Related Content:
Therapies to Decrease Severe Respiratory Syncytial Virus Illness Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus

Chronic pruritus, defined as itch lasting more than 6 weeks, affects approximately 22% of people in their lifetime. In this JAMA clinical review podcast, dermatologist Daniel C. Butler, MD, from the University of Arizona College of Medicine, joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss evaluation and management of chronic pruritus.

Related Content:
Chronic Pruritus